MYO · Myomo, Inc. · Metrics
Market Cap
$53.07M
Shares
39.61M
MYO metrics
69 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$1.33
Market cap
$53.07M
Price action
20 metricsPrice change (1W)
-6.3%
Price change (30D)
-6.3%
Price change (3M)
+2.3%
Price change (6M)
+98.5%
Price change (YTD)
+47.3%
Price change (1Y)
+34.9%
Trailing year
Price change (5Y)
-87.2%
52-week high
$1.86
52-week low
$0.64
Change from 52-week high
-28.0%
Change from 52-week low
+109.4%
Annualized volatility
97.5%
Annualized volatility (3M)
131.2%
Beta
2.0
RSI (14D)
46.1
Price vs SMA 50
+5.8%
Price vs SMA 200
+34.8%
Avg volume (3M)
792,743
Relative volume
0.6
Average dollar volume
$1.04M
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
39.61M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.2×
reciprocal yield 83.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.2×
reciprocal yield 81.5%
P / book
9.1
reciprocal yield 11.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-27.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.8×
reciprocal yield 121.7%
EV / revenue historical average (5Y)
0.8×
reciprocal yield 121.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-05
Profitability
9 metricsGross margin
68.4%
Operating margin
-27.1%
Trailing 12 months
Net margin
-33.5%
Gross profit (TTM)
$29.57M
Operating profit (TTM)
−$11.70M
Net income (TTM)
−$14.51M
Trailing 12 months
Diluted EPS (TTM)
$-0.34
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+21.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$43.26M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.7%
Year over year · more shares
Revenue CAGR (3Y)
+38.1%
Revenue CAGR (5Y)
+40.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-248.9%
Return on assets
-41.0%
Debt / equity
2.1
Current ratio
2.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$1.47M
Latest balance sheet
Cash & equivalents
$11.22M
Total assets
$35.34M
Total debt
$11.98M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$7.11M
Capital expenditures (TTM)
$1.21M
R&D (TTM)
$6.50M
SG&A (TTM)
$18.78M
Stock compensation (TTM)
$2.79M
R&D / revenue
15.0%
Stock compensation / revenue
6.4%
Ownership (13F)
3 metrics13F filers
79
13F filer change QoQ
-3
Institutional ownership
31.0%
Short interest
3 metricsShort interest
2.8%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
44 / 100
Insider activity
2 metricsNet insider buying (90D)
−$51,479
Insider-sentiment score
36 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1369290
CUSIP
62857J201
13F (30d)
50 filings
50 filers
Visit website
Investor relations